In melanomas harboring activated BRAF, activation of MEK/ERK is achieved by this isoform [27], while in melanomas with oncogenic RAS, the activating signal to ERK is passed by the WTCRAF, due to deregulation of its inhibition [28]. This evidence concerns the gene MAP2K7 and melanoma.